Home / Company

About EVANIUM

We believe in ingredients that actually work

The benefits of natural ingredients should make a real difference in people’s lives. EVANIUM bridges the gap between what nature offers and what consumers actually experience, with OPTISOLV® Technology developed in Regensburg, Germany.

The EVANIUM team at the BioPark Regensburg
2019

Founded in Regensburg, Germany

4

Patent applications

12+

Team members and industry experts

EUR 2.5 M

Total funding raised, incl. EUR 2.2 M seed round 2026

Developed in Germany. Produced in France.

From the lab in Regensburg to production at scale

Every OPTISOLV® ingredient is formulated and characterised in our own laboratories before it goes into production with our partners.

Laboratories

Two laboratories and office space at the BioPark Regensburg for formulation and analytics.

Production

Produced in France by partners in a HACCP, ISO 22000 and FDA-registered facility, with a capacity of over 10 t of powder per day.

Markets

Customers and partners in the EU, the US, and Latin America, in nutraceuticals, pharma, functional foods and cosmetics.

HPLC analysis in the EVANIUM laboratory at the BioPark Regensburg

Our story

From research project to award-winning ingredients

2019-2021

Fundamental research and development

2022

Technology optimisation, pre-seed funding

2023

Third patent application, first product launch in the US

2024

900 kg of material produced and sold, first customer project, development of a topical system

2025

Launch of 4 products, over 3 tons of material produced and sold, fourth patent application

2026

EUR 2.2 M seed funding, trade fair exhibitions, award “Most Innovative Nutraceutical Ingredient” at Vitafoods Europe

Our team

The people behind OPTISOLV®

Scientists, formulators and industry experts working on one goal: to unlock the full potential of ingredients.

Felix Rolka, Co-Founder and CEO of EVANIUM

Felix Rolka

Co-Founder & CEO

David Ofner, Co-Founder and CTO of EVANIUM

David Ofner

Co-Founder & CTO

Eliza Weitzel, Founders Associate

Eliza Weitzel

Founders Associate

Dr David Stelzig, Scientific Research Specialist at EVANIUM

Dr. David Stelzig

Scientific Research Specialist

Dr Andreas Bosch, Head of Quality at EVANIUM

Dr. Andreas Bosch

Head of Quality

Dr. Andreas Wuzik

Head of Operations

Ludwig d'Heureuse, Formulation Scientist

Ludwig d'Heureuse

Formulation Assistant

Larissa Reetz, Formulation Assistant at EVANIUM

Larissa Reetz

Formulation Assistant

Laura Schicker, Marketing at EVANIUM

Laura Schicker

Marketing

Daniel Jesser, Finance at EVANIUM

Daniel Jesser

Finance

Niklas Kielkopf, Formulation Assistant

Niklas Kielkopf

Formulation Assistant

Lea Hoffmann, Formulation Assistant

Lea Hoffmann

Formulation Assistant

Carlo Werkmann, Co-Founder and Attorney at Law at EVANIUM

Carlo Werkmann

Co-Founder & Attorney at Law

Board of investors

Experience from pharma, OTC and consumer health

Dr Hanns-Georg Klein, Founder and Partner at Acmaios Innovations

Dr. Hanns-Georg Klein

Founder & Partner, Acmaios Innovations

Stefan Kilian, former manager at Boehringer Ingelheim

Stefan Kilian

25+ years manager, Boehringer Ingelheim

Prof Dr Gerald Huber, former C-level executive at Ratiopharm

Prof. Dr. Gerald Huber

13+ years C-level, Ratiopharm

Martina Gripp, OTC marketing expert, Boehringer Ingelheim

Martina Gripp

15+ years OTC marketing, Boehringer Ingelheim

Dr Boris Jenniches, CEO of Deneva and Goerlich Pharma

Dr. Boris Jenniches

CEO Deneva / Goerlich Pharma

Holger Mannweiler, serial founder in cosmetics and technology

Holger Mannweiler

Serial founder, cosmetics & tech

Adrian Friederich, Principal, Head of Investment, FoodLabs

Adrian Friederich

Principal, Head of Investment, FoodLabs

Julius Strauss, Principal, Investment, FoodLabs

Julius Strauss

Principal, Investment, FoodLabs

Benedikt Stöckert, Managing Partner, Feast Ventures

Benedikt Stöckert

Managing Partner, Feast Ventures

Dr. Alexander Wiegelmann, Managing Partner, Feast Ventures

Dr. Alexander Wiegelmann

Managing Partner, Feast Ventures

Supporters and investors

Backed by investors, programmes and networks

Venture investors, start-up programmes and research networks support EVANIUM on the way from the lab to the market.

FAQ

Questions about EVANIUM

Where is EVANIUM based?

EVANIUM Healthcare GmbH is based at the BioPark Regensburg, Am Biopark 13, 93053 Regensburg, Germany, with two laboratories and office space.

EVANIUM was founded in 2019 in Regensburg by Felix Rolka (CEO), David Ofner (CTO) and Carlo Werkmann.

OPTISOLV® ingredients are developed in Germany and produced in France by partners in a HACCP, ISO 22000 and FDA-registered facility.

We are always looking for passionate people to join our mission. Open positions are listed on our careers page.

Join us

We are always looking for passionate people to join our mission.